Diagnos Laboratorium (Indonesia) Today
| DGNS Stock | IDR 220.00 4.00 1.79% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Diagnos Laboratorium is selling for 220.00 as of the 30th of November 2024. This is a 1.79 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 212.0. Diagnos Laboratorium has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Diagnos Laboratorium Utama are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia. Diagnos Laboratorium operates under Diagnostics Research classification in Indonesia and is traded on Jakarta Stock Exchange. The company has 1.25 B outstanding shares. More on Diagnos Laboratorium Utama
Moving together with Diagnos Stock
Moving against Diagnos Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Diagnos Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Diagnos Laboratorium's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Diagnos Laboratorium or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Diagnostics & Research, Healthcare (View all Sectors) |
Diagnos Laboratorium Utama (DGNS) is traded on Jakarta Exchange in Indonesia and employs 568 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 302.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Diagnos Laboratorium's market, we take the total number of its shares issued and multiply it by Diagnos Laboratorium's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Diagnos Laboratorium operates under Healthcare sector and is part of Diagnostics & Research industry. The entity has 1.25 B outstanding shares.
Diagnos Laboratorium Utama has accumulated about 52.8 B in cash with 58.87 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 42.24.
Check Diagnos Laboratorium Probability Of Bankruptcy
Ownership AllocationDiagnos Laboratorium retains a total of 1.25 Billion outstanding shares. Diagnos Laboratorium Utama shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 80.0 percent of Diagnos Laboratorium outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Diagnos Ownership Details
Diagnos Laboratorium Risk Profiles
Although Diagnos Laboratorium's alpha and beta are two of the key measurements used to evaluate Diagnos Laboratorium's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.35 | |||
| Standard Deviation | 3.47 | |||
| Variance | 12.04 | |||
| Risk Adjusted Performance | (0.09) |
Diagnos Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Diagnos Laboratorium without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Diagnos Laboratorium Corporate Management
Elected by the shareholders, the Diagnos Laboratorium's board of directors comprises two types of representatives: Diagnos Laboratorium inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Diagnos. The board's role is to monitor Diagnos Laboratorium's management team and ensure that shareholders' interests are well served. Diagnos Laboratorium's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Diagnos Laboratorium's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fanfan Riksani | Co Sec | Profile | |
| R Ridwan | Head Unit | Profile | |
| Dennis Jacobus | Medical Director | Profile | |
| Mesha Sini | Pres Director | Profile |
Other Information on Investing in Diagnos Stock
Diagnos Laboratorium financial ratios help investors to determine whether Diagnos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diagnos with respect to the benefits of owning Diagnos Laboratorium security.